The MMRF is actively working with national leaders and other blood cancer organizations to advance public policy initiatives that accelerate and intensify efforts to bring new therapies to patients with blood-related cancers.

Recognized as a leader in identifying and funding cutting-edge myeloma research, the MMRF represents the myeloma community on the Leukemia, Lymphoma and Myeloma Progress Review Group (LLM-PRG), a blue-ribbon panel convened by the NCI to identify research challenges and priorities in blood cancer. The MMRF is also well represented on the following advocacy and scientific committees:

• The Cancer Leadership Council
• Director's Consumer Liaison Group
• Consumer Advocates in Research Related Activities, Planning Oversight Committee
• National Dialogue on Cancer, Committee on Public Private Partnerships